Skip to main content
. Author manuscript; available in PMC: 2014 Aug 5.
Published in final edited form as: Expert Opin Drug Discov. 2013 Jul 12;8(10):1181–1189. doi: 10.1517/17460441.2013.817988

Table 2.

Preclinical findings and interpretation of data.

Preclinical data Interpretation
Tumor inhibition and regression Drug efficacy
Pharmacokinetics Tolerability or toxicity profiles
Pharmacodynamics Target expression relevant for drug action
Tumor growth Resistance—Target addiction; activation of survival pathways
Biomarkers Predictive of response to drug